ScreenerHero
ONCOOncopeptides AB (publ)
STO · SE · Healthcare · Biotechnology · oncopeptides.com
1.676SEK-3.90%Mkt Cap: 61.14M $P/E: —

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
HeadlineSourceTime
Older
Startskott för Oncopeptides kliniska studie i hjärncancer
lifesciencenordic.com
Bonesupport faller och Oncopeptides lyfter
Affärsvärlden
Oncopeptides AB (FRA:OND) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Strategic ...

Oncopeptides AB (FRA:OND) reports impressive sales growth and strategic advancements, despite facing regional hurdles and regulatory delays.

GuruFocus.com
Oncopeptides vd diskuterar emission, försäljning och glioblastom
BBiostock
Oncopeptides genomför nyemission om 200 miljoner
DDagens PS
Oncopeptides AB (STU:OND) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ...

Despite challenges in key markets, Oncopeptides AB (STU:OND) reports significant sales growth and outlines strategic initiatives to enhance its pipeline and market reach.

GuruFocus.com
Oncopeptides gör nyemission – tar in 200 miljoner
Privata Affärer
Oncopeptides AB (FRA:OND) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amid Strategic ...

Oncopeptides AB (FRA:OND) reports a 174% increase in net sales and robust gross margins, while navigating operational and market expansion hurdles.

GuruFocus.com
Oncopeptides AB (STU:OND) Q2 2025 Earnings Call Highlights: Strong Sales Growth Amid Financial ...

Oncopeptides AB reports significant sales growth and strategic progress, but faces ongoing financial hurdles and partnership delays.

GuruFocus.com
Oxcias valberedning föreslår Eva Nordström till ny styrelseledamot
Cision News